Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Epidemiological determinants of canine transmissible venereal tumor in Northeastern Brazil: Insights from a retrospective case-control analysis. [PDF]
Dos Santos Barbosa FA +5 more
europepmc +1 more source
A GeoAI framework for detecting risk zones from illegal dumping sites in Khulna, Bangladesh. [PDF]
Das S, Morshed MM.
europepmc +1 more source
Comparative analysis of polymerization efficiency and degradation indicators of adhesive resin cements and preheated restorative composites. [PDF]
Jordáki D +6 more
europepmc +1 more source
Analytical Buildings Record (Level 3) at 31-33 High Street, Pershore
Tom Rogers
openalex +1 more source
Bioclimatic comfort and solar responsive urban design in the traditional street texture of Diyarbakir's Suriçi region. [PDF]
Gider KS +3 more
europepmc +1 more source
Environmental and seasonal drivers of microbiological contamination in street-vended foods. [PDF]
Iskandar CF +4 more
europepmc +1 more source

